Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Blueprint Medicines Corporation

BPMC
86,32
-0,50 (-0,58%)
01 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202423:17EDGAR2Form 144 - Report of proposed sale of securities
18/12/202422:31EDGAR2Form 8-K - Current report
18/12/202414:00PRNUSBlueprint Medicines to Present at the 43rd Annual J.P...
17/12/202401:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202422:52EDGAR2Form 144 - Report of proposed sale of securities
07/12/202418:30PRNUSBlueprint Medicines' Continued Leadership in Redefining the..
03/12/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202419:40EDGAR2Form 144 - Report of proposed sale of securities
28/11/202400:51EDGAR2Form 144 - Report of proposed sale of securities
22/11/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
20/11/202422:30EDGAR2Form 144 - Report of proposed sale of securities
12/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202419:44EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
07/11/202423:24EDGAR2Form 144 - Report of proposed sale of securities
30/10/202421:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202412:07EDGAR2Form 8-K - Current report
30/10/202412:00PRNUSBlueprint Medicines Reports Third Quarter 2024 Results and..
16/10/202414:00PRNUSBlueprint Medicines to Report Third Quarter 2024 Financial..
04/10/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202414:00PRNUSBlueprint Medicines to Present at Upcoming Investor..
10/9/202403:22EDGAR2Form 144 - Report of proposed sale of securities
19/8/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:27EDGAR2Form 144 - Report of proposed sale of securities
07/8/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202422:50EDGAR2Form 144 - Report of proposed sale of securities
01/8/202422:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202413:29EDGAR2Form 8-K - Current report
01/8/202413:00PRNUSBlueprint Medicines Reports Second Quarter 2024 Results and..
18/7/202414:00PRNUSBlueprint Medicines to Report Second Quarter 2024 Financial..
09/7/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:00EDGAR2Form 8-K - Current report
07/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:11EDGAR2Form 144 - Report of proposed sale of securities
05/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:40EDGAR2Form 144 - Report of proposed sale of securities
04/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:28EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 87,49 Min: 85,99 Max: 88,02
Chiusura: 86,82

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network